Brief: Cure Pharmaceutical- Filed A Demand To Commence Arbitration With American Arbitration Association Against Canopy Growth Corp
Oct 22 (Reuters) - Cure Pharmaceutical Holding Corp
CURR.PK :
* CURE PHARMACEUTICAL - ON OCT 21, FILED A DEMAND TO
COMMENCE
ARBITRATION WITH AMERICAN ARBITRATION ASSOCIATION AGAINST CANOPY
GROWTH CORP
* CURE PHARMACEUTICAL - ARBITRATION FILED DUE TO CANOPY'S
FAILURE
TO PERFORM UNDER LICENSE AGREEMENT, DATED SEPT 4, 2018
* CURE PHARMACEUTICAL - SEEKING DAMAGES IN EXCESS OF $1
MILLION
Source text: https://bit.ly/2HroS3e
Further company coverage: CURR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenir Wellness Solutions
See all newsBrief: Cure Pharmaceutical Reports Q2 2022 Results
Brief: Cure Pharmaceutical Announces Rob Davidson As New Chairman Of The Board And Appointment Of Rob Costantino As Member Of The Board And Audit Committee Chairman
Brief: Cure Pharmaceutical Holding Q1 Revenue $1.5 Million
Brief: CURE Pharmaceutical Augments Its Existing U.S. DEA License
Brief: Cure Pharmaceutical Receives FDA Approval For Its IND Application For Curefilm Blue